Page 13 - பழுப்பு பள்ளி ஆஃப் பொது ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A doctor inoculates someone with AstraZeneca s Covid-19 vaccine. Michele Tantussi/Getty Images A week after receiving the AstraZeneca Covid-19 vaccine, a 37-year-old woman in Norway went to the emergency department with fever and persistent headaches. A CAT scan of her head showed a blood clot in blood vessels involved in draining the brain, but her levels of platelets, involved in clotting, were low. She was treated with platelet infusions and a blood thinner, but had a bleed in her brain the next day. She underwent surgery to relieve the pressure on her brain but died two days later. This is the side effect, known as cerebral venous sinus thrombosis, that has caused a week of worries around the Covid-19 vaccine developed by AstraZeneca. On Tuesday, the U.S. government said that it had seen the same effect six times among the 6.8 million people given a dose of a similar vaccine, from Johnson & Johnson, and that it recommended a pause on use of that vaccine “out

South africaUnited statesBrown schoolDavid juurlinkAstrazeneca covidDan barouchPaul offitTheodore werkentinAshish jhaPeter arlettMcmaster universityBeth israel deaconess medical centerDrug administrationBrown school of public healthSunnybrook health sciences centreEuropean medicines agency